Revolution Medicines, Inc.
BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS

Last updated:

Abstract:

The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Status:
Application
Type:

Utility

Filling date:

22 Jul 2019

Issue date:

16 Jan 2020